🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study

Recruitingn/aAges 18 Years - anyAllKanuni Sultan Suleyman Training and Research Hosp…
NCT07677033 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Functional Muscle-Bone Incongruity Index (FKUI) is a novel approach developed to evaluate the relationship between muscle function and bone health. This prospective observational study aims to investigate the clinical applicability of FKUI, which combines handgrip strength, total hip bone mineral density (BMD), and lumbar-hip BMD discordance. Approximately 200 adult participants undergoing routine DXA assessment will be enrolled. The study will examine whether the combined evaluation of muscle function and bone health parameters provides a more comprehensive assessment of musculoskeletal status than individual measures alone.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older * Attendance at the Physical Medicine and Rehabilitation outpatient clinic * Scheduled to undergo routine bone mineral density assessment by DXA as part of clinical evaluation * Ability to perform handgrip strength testing * Availability of lumbar spine and total hip bone mineral density measurements suitable for analysis * Ability and willingness to provide written informed consent Exclusion Criteria: Exclusion Criteria: * Age younger than 18 years * Secondary causes of osteoporosis (e.g., hyperparathyroidism, Cushing syndrome, malignancy, or other conditions affecting bone metabolism) * History of metabolic bone disease * Major trauma or fracture within the previous 6 months * Upper extremity disorders that may significantly affect handgrip strength measurement (e.g., severe osteoarthritis, neurological disorders, major deformities) * DXA measurements that are technically inadequate or unsuitable for analysis * Refusal or inability to provide written informed consent
💊

What it tests

  • Not listed
📍

Where

1 site
Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
Küçükçekmece, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy